Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALPI | P09923 | 1/20 | 0.58 |
| ▸ | PKM | P14618 | 1/20 | 0.58 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.58 |
| ▸ | XIAP | P98170 | 1/20 | 0.58 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.58 |
| ▸ | SLC15A1 | P46059 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | LTA4H | P09960 | 1/20 | 0.47 |
| ▸ | TYR | P14679 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.46 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.46 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.46 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.45 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5801115 | 1.00 | ALPI (0.58) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL27926007 | 1.00 | ALPI (0.58) | ALPIPKMPTGS1XIAPSLC7A5 | |
| Hydrochloric Acid SCHEMBL5811213 | 0.98 | ALPI (0.56) | ALPIPKMPTGS1XIAPSLC7A5 | |
| Hydrochloric Acid SCHEMBL5811215 | 0.98 | ALPI (0.56) | ALPIPKMPTGS1XIAPSLC7A5 | |
| Iodide SCHEMBL28191562 | 0.97 | ALPI (0.54) | ALPIPKMPTGS1XIAPSLC7A5 | |
| Sulfuric Acid SCHEMBL10354899 | 0.94 | ALPI (0.51) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL2734875 | 0.90 | ALPI (0.54) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL216480 | 0.90 | ALPI (0.54) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL26359430 | 0.90 | ALPI (0.66) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL15679078 | 0.90 | ALPI (0.66) | ALPIPKMPTGS1XIAPSLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102093578-A | Preparation method of shape-controllable amino-acid ester (with side group benzene ring) substituted polyphosphazene microspheres | UNIV BEIJING CHEMICAL | 2011-06-15 | — | — | CN | claimed |
| EP-1603549-A2 | IMPROVED BIOAVAILABILITY AND IMPROVED DELIVERY OF ACIDIC PHARMACEUTICAL DRUGS | Yu, Ruey J., Dr. (US) | 2005-12-14 | — | — | EP | claimed |
| US-20040220264-A1 | Bioavailability and improved delivery of acidic pharmaceutical drugs | YU RUEY J | 2004-11-04 | — | — | US | claimed |
| WO-2004082628-A2 | IMPROVED BIOAVAILABILITY AND IMPROVED DELIVERY OF ACIDIC PHARMACEUTICAL DRUGS | YU RUEY J (US) | 2004-09-30 | — | — | WO | claimed |
| CN-120040435-A | Mangiferin and derivatives thereof, preparation method and medical application thereof | 安徽中医药大学 | 2025-05-27 | — | — | CN | disclosed |
| EP-2976400-B1 | ZUSAMMENSETZUNG, ENTHALTEND ALLOPHANATE | VENCOREX FRANCE (FR) | 2024-07-24 | — | — | EP | disclosed |
| US-20230151049-A1 | Compounds Useful in HIV Therapy | VIIV HEALTHCARE COMPANY (US) | 2023-05-18 | — | — | US | disclosed |
| US-10399924-B2 | Deuterium substituted fumarate derivatives | BIOGEN MA INC. (US) | 2019-09-03 | — | — | US | disclosed |
| US-10208045-B2 | Aza-pyridone compounds and uses thereof | ALIOS BIOPHARMA, INC. (US) | 2019-02-19 | — | — | US | disclosed |
| CN-105164219-B | Allophanate composition | 温科莱斯法国公司 | 2018-11-06 | — | — | CN | disclosed |
| CN-107427589-A | Non-aqueous solutions of enzyme-polymer conjugates and related methods | 卡内基梅隆大学 | 2017-12-01 | — | — | CN | disclosed |
| CN-105085321-B | A kind of preparation method of N methoxycarbonyl groups L Terleus | 浙江九洲药业股份有限公司 | 2017-11-24 | — | — | CN | disclosed |
| WO-2004082628-A2 | IMPROVED BIOAVAILABILITY AND IMPROVED DELIVERY OF ACIDIC PHARMACEUTICAL DRUGS | YU RUEY J (US) | 2004-09-30 | — | — | WO | disclosed |
| WO-2003106655-A2 | FIBROUS PROTEIN-IMMOBILIZATION SYSTEMS | THE UNIVERSITY OF AKRON (US) | 2003-12-24 | — | — | WO | disclosed |
| EP-0461043-A2 | Enantiomer separation by transesterification | SEPRACOR, INC. (US) | 1991-12-11 | — | — | EP | disclosed |
| EP-0178553-B1 | PROCESS FOR THE PRODUCTION OF AROMATIC SUBSTITUTED L-AMINO ACIDS | HOECHST AKTIENGESELLSCHAFT (DE) | 1990-09-12 | — | — | EP | disclosed |
| US-4898966-A | ESTERIFICATION OF PHENYLALANINE HYDROCHLORIDE WITH N-PROPANOL; EFFICIENCY | HOECHST AKTIENGESELLSCHAFT (DE) | 1990-02-06 | — | — | US | disclosed |
| EP-0313909-A2 | Process for the preparation of phenyl alanine-n-propyl ester hydrochloride | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-05-03 | — | — | EP | disclosed |
| EP-0178553-A2 | Process for the production of aromatic substituted L-amino acids | HOECHST AKTIENGESELLSCHAFT (DE) | 1986-04-23 | — | — | EP | disclosed |
| EP-0065835-B1 | M-4 AND ISO M-4 DERIVATIVES, THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM | SANKYO COMPANY LIMITED (JP) | 1985-11-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10399924-B2 | Deuterium substituted fumarate derivatives | FH, HTT, FAHD1 | ALPI 3981/4885PKM 1172/4885PTGS1 3264/4885 |
| US-10208045-B2 | Aza-pyridone compounds and uses thereof | PNPO, ITPA, PDXK | ALPI 523/4885PKM 1701/4885PTGS1 3507/4885 |
| US-20230151049-A1 | Compounds Useful in HIV Therapy | CCR5, CD4, NPC1 | ALPI 2019/4885PKM 915/4885PTGS1 1294/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.